Inhaled epoprostenol (prostacyclin) and pulmonary hypertension before cardiac surgery

Journal of Thoracic and Cardiovascular Surgery

Volumn 125, Issue 3, 2003, Pages 642-649

  Haché, Manon ^a   Denault, André ^a   Bélisle, Sylvain ^a   Robitaille, Danielle ^a   Couture, Pierre ^a   Sheridan, Peter ^a   Pellerin, Michel ^a   Babin, Denis ^a   Noël, Nicolas ^a   Guertin, Marie Claude ^a   Martineau, Raymond ^a   Dupuis, Jocelyn ^a  

^a MONTREAL HEART INSTITUTE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANESTHETIC AGENT; HEPARIN; LORAZEPAM; MIDAZOLAM; MORPHINE; NEUROMUSCULAR BLOCKING AGENT; PANCURONIUM; PLACEBO; PROSTACYCLIN; SCOPOLAMINE; SUFENTANIL;

ADULT; AGED; ARTICLE; BLEEDING; CARDIOVASCULAR SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART CATHETERIZATION; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMIC PARAMETERS; HUMAN; LUNG ARTERY; MALE; NEBULIZER; OXYGENATION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RANDOMIZED CONTROLLED TRIAL; THROMBOCYTE AGGREGATION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

EID: 0037348597     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1067/mtc.2003.107     Document Type: Article

References (30)

1. Bernstein AD, Parsonnet V. Bedside estimation of risk as an aid for decision-making in cardiac surgery. Ann Thorac Surg. 2000;69:823-8.
2. Radermacher P, Santak B, Wust HJ, Tarnow J, Falke KJ. Prostacyclin for the treatment of pulmonary hypertension in the adult respiratory distress syndrome: effects on pulmonary capillary pressure and ventilation-perfusion distributions. Anesthesiology. 1990;72:238-44.
3. Goldman AP, Delius RE, Deanfield JE, Macrae DJ. Nitric oxide is superior to prostacyclin for pulmonary hypertension after cardiac operations. Ann Thorac Surg. 1995;60:300-5.
4. Haraldsson A, Kieler-Jensen N, Nathorst-Westfelt U, Bergh CH, Ricksten SE. Comparison of inhaled nitric oxide and inhaled aerosolized prostacyclin in the evaluation of heart transplant candidates with elevated pulmonary vascular resistance. Chest. 1998;114:780-6.
5. 2) versus inhaled nitric oxide in adult respiratory distress syndrome. Am J Respir Crit Care Med. 1996;154:1671-7.
6. van Heerden PV, Barden A, Michalopoulos N, Bulsara MK, Roberts BL. Dose-response to inhaled aerosolized prostacyclin for hypoxemia due to ARDS. Chest. 2000;117:819-27.
7. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 1996;124:820-4.
8. Walmrath D, Schneider T, Pilch J, Grimminger F, Seeger W. Aerosolised prostacyclin in adult respiratory distress syndrome. Lancet. 1993;342:961-2.
9. Montalescot G, Drobinski G, Meurin P, et al. Effects of prostacyclin on the pulmonary vascular tone and cardiac contractility of patients with pulmonary hypertension secondary to end-stage heart failure. Am J Cardiol. 1998;82:749-55.
10. Rich S, McLaughlin VV. The effects of chronic prostacyclin therapy on cardiac output and symptoms in primary pulmonary hypertension. J Am Coll Cardiol. 1999;34:1184-7.
11. van Heerden PV, Gibbs NM, Michalopoulos N. Effect of low concentrations of prostacyclin on platelet function in vitro. Anaesth Intensive Care. 1997;25:343-6.
12. 2) est un traitement complémentaire efficace de l'hypertension pulmonaire et de l'hypoxie observées en salle d'opération et à l'unité des soins intensifs]. Can J Anaesth. 2001;48: 924-9.
13. Moraes D, Loscalzo J. Pulmonary hypertension: newer concepts in diagnosis and management. Clin Cardiol. 1997;20:676-82.
14. Fyrenius A, Wigstrom L, Bolger AF, et al. Pitfalls in Doppler evaluation of diastolic function: insights from 3-dimensional magnetic resonance imaging. J Am Soc Echocardiogr. 1999;12:817-26.
15. Schnittger I, Fitzgerald PJ, Daughters GT, et al. Limitations of comparing left ventricular volumes by two dimensional echocardiography, myocardial markers and cineangiography. Am J Cardiol. 1982;50: 512-9.
16. Bernard F, Denault A, Babin D, et al. Diastolic dysfunction is predictive of difficult weaning from cardiopulmonary bypass. Anesth Analg. 2001;92:291-8.
17. Couture P, Denault AY, Carignan S, Boudreault D, Babin D, Ruel M. Intraoperative detection of segmental wall motion abnormalities with transesophageal echocardiography. Can J Anaesth. 1999;46:827-31.
18. 2 aerosol versus nitric oxide for selective pulmonary vasodilation in hypoxic pulmonary vasoconstriction. Eur Surg Res. 1993;25:329-40.
19. Zobel G, Dacar D, Rodl S, Friehs I. Inhaled nitric oxide versus inhaled prostacyclin and intravenous versus inhaled prostacyclin in acute respiratory failure with pulmonary hypertension in piglets. Pediatr Res. 1995;38:198-204.
20. Max M, Kuhlen R, Dembinski R, Rossaint R. Effect of aerosolized prostacyclin and inhaled nitric oxide on experimental hypoxic pulmonary hypertension. Intensive Care Med. 1999;25:1147-54.
21. Zwissler B, Welte M, Messmer K. Effects of inhaled prostacyclin as compared with inhaled nitric oxide on right ventricular performance in hypoxic pulmonary vasoconstriction. J Cardiothorac Vasc Anesth. 1995;9:283-9.
22. Bein T, Metz C, Keyl C, Sendtner E, Pfeifer M. Cardiovascular and pulmonary effects of aerosolized prostacyclin administration in severe respiratory failure using a ventilator'nebulization system. J Cardiovasc Pharmacol. 1996;27:583-6.
23. Olschewski H. Ghofrani HA, Walmrath D, et al. Inhaled prostacyclin and iloprost in severe pulmonary hypertension secondary to lung fibrosis. Am J Respir Crit Care Med. 1999;160:600-7.
24. Mikhail G, Gibbs J, Richardson M, et al. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J. 1997;18:1499-504.
25. Haraldsson A, Kieler-Jensen N, Ricksten SE. Inhaled prostacyclin for treatment of pulmonary hypertension after cardiac surgery or heart transplantation: a pharmacodynamic study. J Cardiothorac Vasc Anesth. 1996;10:864-8.
26. Burghuber OC, Silberbauer K, Haber P, Sinzinger H, Elliott M, Leithner C. Pulmonary and antiaggregatory effects of prostacyclin after inhalation and intravenous infusion. Respiration. 1984;45:450-4.
27. Haraldsson A, Kieler-Jensen N, Wadenvik H, Ricksten SE. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Intensive Care Med. 2000;26:188-94.
28. Sharp DS, Beswick AD, O'Brien JR, Renaud S, Yarnell JW, Elwood PC. The association of platelet and red cell count with platelet impedance changes in whole blood and light-scattering changes in platelet rich plasma: evidence from the Caerphilly Collaborative Heart Disease Study. Thromb Haemost. 1990;64:211-5.
29. Coates AL, Ho SL. Drug administration by jet nebulization. Pediatr Pulmonol. 1998;26:412-23.
30. Fink JB. Aerosol device selection: evidence to practice [in process citation]. Respir Care. 2000;45:874-85.